Search for: "Endo Pharmaceuticals Inc." Results 101 - 120 of 154
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Oct 2011, 5:08 pm
J&J’s Gynecare TVT later became a predicate for the IVS Tunneller I, made by Dublin-based Covidien, and the Sparc Sling, made by the American Medical Systems unit of Endo Pharmaceuticals Holdings Inc. [read post]
30 Sep 2011, 8:05 am by Ed Wallis
Fellow mesh makers, including Johnson & Johnson (NYSE:JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
8 Sep 2011, 9:51 pm
Manufacturers including J&J and Endo Pharmaceuticals Holdings Inc. [read post]
8 Sep 2011, 9:55 am
If accepted by the FDA, manufacturers, such as Johnson & Johnson, Endo Pharmaceuticals Holdings, Inc. and C.R. [read post]
24 Aug 2011, 12:33 am by Marie Louise
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
14 Jul 2011, 8:40 pm
(now part of Pennsylvania-based Endo Pharmaceuticals) and Coloplast. [read post]
4 Jul 2011, 9:59 pm by Patent Docs
Endo Pharmaceuticals Inc. v. [read post]
22 Jun 2011, 4:09 am by Marie Louise
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
18 May 2011, 9:20 pm by Patent Docs
The subject matter was controlled-release oxymorphone formulations, assigned to Endo Pharmaceuticals Inc. in three applications: U.S. [read post]
17 May 2011, 10:37 pm
Endo Pharmaceuticals appealed three applications related to time-released opioids. [read post]
4 May 2011, 7:52 am by Tron Emptage
  Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis   Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs   Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies   Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms   Fentanyl Fentanyl Extended Release Transdermal System Watson   Methadone … [read post]
22 Mar 2011, 4:21 pm by Marie Louise
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]